BTTX
Better Therapeutics, Inc. Common Stock
BTTX
BTTX
Delisted
BTTX was delisted on the 15th of March, 2024.
17 hedge funds and large institutions have $1.75M invested in Better Therapeutics, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
50% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 6
Holders
17
Holding in Top 10
–
Calls
$360K
Puts
$191K
Top Buyers
| 1 | +$22.7K | |
| 2 | +$1.82K | |
| 3 | +$228 | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$149 |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$20 |
Top Sellers
| 1 | -$209K | |
| 2 | -$19.6K | |
| 3 | -$19K | |
| 4 |
Two Sigma Investments
New York
|
-$7.38K |
| 5 |
Millennium Management
New York
|
-$2.94K |